Register to join the live satellite session at Consortium of Universities for Global Health 2021 Virtual Conference. This session will explore how collaborations and strategic partnerships can harness the power of data to tackle the most devastating health issues. We ... Read more

Based on the Nuffield Council on Bioethics report, this new course explores core ethical issues that arise during research in global health emergencies, and ... Read more

Those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and with underlying comorbidities, posing a risk for drug-drug interactions (DDIs). See the interactions checker and free prescribing resources to aid the use of experimental agents in the ... Read more

Warnings on self-medication / stopping medicines; pharmacological considerations in older people; medication errors, interactions & ADRs; off-label use; supply management; misleading claims / fraud; & clinical research Read more

An article in Drug Safety highlights the role of pharmacovigilance in the pandemic situation, and more specifically, the role of the International Society of Pharmacovigilance (ISoP) during the current coronavirus 2019 (COVID-19) outbreak Read more

This webinar covered the importance of integrating clinical pharmacology and translational medicine principles in COVID-19 dosing strategy and study design with a demonstration of PKPD simulation tools available on covidpharmacology.com using recently completed analyses for ivermectin, chloroquine, and lopinavir/ritonavir Read more

Dissemination of information on the safety and efficacy of pharmaceutical products, based on information received from the WHO's network of "drug information officers", bulletins and journals etc. Read more

If you are caring for patients with COVID-19, you may register for free at medsafetyscan.org and log in to use the program to enter patients' clinical risk factors and their medicines. The program quickly reports if any are on the ... Read more

IDDO’s Medicine Quality Research Group has developed a system for collating and curating global data on the quality of essential medical products and occurrence of substandard and falsified (SF) medical products in the lay press – the MQM Globe. Read more

The module was developed as part of the SCOPE Joint Action project to raise awareness levels of ADR reporting. You are requested to complete a short survey upon completion of the free e-learning. Read more

Six modules about Adverse Drug Reactions developed by NHS Education for Scotland and the Yellow Card Centre Scotland (Centre for Adverse Reactions to Drugs Scotland); their incidence & public health implications, the different classifications of ADRs & drug allergies, how ... Read more

The International Society of Pharmacovigilance’s (ISoP’s) held a Mid-Year Symposium and Training Course in Nairobi, Kenya brining together nearly 100 ISoP members from across Africa and beyond, including from government/regulatory bodies, the pharmaceutical industry and academia. The event concluded with ... Read more

We have a growing list of articles detailing personal experiences of post-graduate study or working in pharmacovigilance. This is intended to inspire others who may be considering their own PV journey. Would you like to be featured? We'd love to ... Read more

PAVIA and PROFORMA are two large, coordinated, African pharmacovigilance consortia that are part of the EDCTP2 programme supported by the European Union’s Horizon 2020 research and innovation programme Read more

Overview of presentations and key points discussed during the seventh meeting of the Global Vaccine Safety Initiative (GVSI), Santiago, Chile, 8–9 October 2018 Read more

See the latest CIOMS Newsletter here Read more

Regulatory systems play a key role in assuring the quality, safety, and efficacy of medical products. The Global Benchmarking Tool (GBT) represents the primary means by which the WHO objectively evaluates regulatory systems, as mandated by WHA Resolution 67.20 on ... Read more

The new WHO PV Toolkit comprises resources and information for the practice of pharmacovigilance, with a special focus on low- and middle-income countries. Read more

FDA is developing four methodological patient-focused drug development (PFDD) guidance documents to address, in a stepwise manner, how stakeholders can collect and submit patient experience data and other relevant information from patients and caregivers for medical product development and regulatory ... Read more

The EMA has published a Q&A document for public consultation until 31 July 2019. This supplements the CHMP Data Monitoring Committee Guideline, clarifying the role and necessity for a Data Monitoring Committee (DMC) in different phases of drug development and ... Read more

A new ENCePP Code of Conduct provides a set of rules and principles for pharmacoepidemiology and pharmacovigilance studies to promote scientific independence and transparency throughout the research process. Read more

IMDRF Terminologies for Categorized Adverse Event Reporting (AER): terms, terminology structure and codes. A Proposed Document has been released by the International Medical Device Regulators Forum (IMDRF) Adverse Events Terminology Working Group to include the proposed third edition of Document ... Read more

A new framework for a core curriculum for university teaching of pharmacovigilance (PV) has been published, describing five key aspects that focus on clinical practice: the importance of PV in the context of pharmacotherapy and preventing, recognizing, managing and reporting ... Read more

The new African Medicines Agency (AMA) will ensure coordination and strengthening of continental initiatives to harmonise medical products regulation, provide guidance and technical support to improve access to quality, safe and efficacious medical products and health technologies. See https://t.co/y2e8HWEMPu Read more

Can't find what you're looking for? You can browse news items previously featured on our home page in our News Archive! Read more